Measurement of total and free malondialdehyde by gas-chromatography mass spectrometry-comparison with high-performance liquid chromatography methology

Free Radical Research

Volumn 47, Issue 8, 2013, Pages 651-656

  Zelzer, S ^a   Oberreither, R ^a   Bernecker, C ^a   Stelzer, I ^a   Truschnig Wilders, M ^a   Fauler, G ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

GC MS; HPLC; Malondialdehyde; Oxidative stress; Total and free MDA

Indexed keywords

2,4 DINITROPHENYLHYDRAZINE; DEUTERIUM; MALONALDEHYDE; POLYUNSATURATED FATTY ACID; THIOBARBITURIC ACID;

ACCURACY; ADULT; ARTICLE; CALIBRATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYMATIC DEGRADATION; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IONIZATION; LIPID PEROXIDATION; MASS FRAGMENTOGRAPHY; NORMAL HUMAN; SENSITIVITY AND SPECIFICITY;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALONDIALDEHYDE;

EID: 84880534894     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2013.812205     Document Type: Article

References (22)

1. Kramer JH, Misik V, Weglicki WB. Lipid peroxidationderived free radical production and postischemic myocardial reperfusion injury. Ann N Y Acad Sci 1994;723:180-196.
2. De Vecchi AF, Bamonti F, Novembrino C, Ippolito S, Guerra L, Lonati S, et al. Free and total plasma malondialdehyde in chronic renal insuffi ciency and in dialysis patients. Nephrol Dial Transplant 2009;24:2524-2529.
3. Walter MF, Jacob RF, Jeff ers B, Ghadanfar MM, Preston GM, Buch J, Mason RP, Study P. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. J Am Coll Cardiol 2004;44:1996-2002.
4. Janero DR. Malondialdehyde and thiobarbituric acidreactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990;9:515-540.
5. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990;186:407-421.
6. Cordis GA, Maulik N, Bagchi D, Engelman RM, Das DK. Estimation of the extent of lipid peroxidation in the ischemic and reperfused heart by monitoring lipid metabolic products with the aid of high-performance liquid chromatography. J Chromatogr 1993; 632: 97-103.
7. Cighetti G, Debiasi S, Paroni R, Allevi P. Free and total malondialdehyde assessment in biological matrices by gas chromatography-mass spectrometry: what is needed for an accurate detection. Anal Biochem 1999;266:222-229.
8. Khoschsorur GA, Winklhofer-Roob BM, Rabl H, Auer T, Peng Z, Schaur RJ. Evaluation of a sensitive HPLC method for the determination of malondialdehyde, and application of the method to diff erent biological materials. Chromatographia 2000;52:181-184.
9. Pilz J, Meineke I, Gleiter CH. Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2,4-dinitrophenylhydrazine derivative. J Chromatogr B Biomed Sci Appl 2000;742:315-325.
10. Breusing N, Grune T, Andrisic L, Atalay M, Bartosz G, Biasi F, et al. An inter-laboratory validation of methods of lipid peroxidation measurement in UVA-treated human plasma samples. Free Radic Res 2010; 44: 1203-1215.
11. Cordis GA, Bagchi D, Maulik N, Das DK. High-performance liquid chromatographic method for the simultaneous detection of malonaldehyde, acetaldehyde, formaldehyde, acetone and propionaldehyde to monitor the oxidative stress in heart. J Chromatogr A 1994; 661: 181-191.
12. Maboudou P, Mathieu D, Bachelet H, Wiart JF, Lhermitte M. Detection of oxidative stress. Interest of GC-MS for malondialdehyde and formaldehyde monitoring. Biomed Chromatogr 2002;16:199-202.
13. Draper HH, Csallany AS, Hadley M. Urinary aldehydes as indicators of lipid peroxidation in vivo. Free Radic Biol Med 2000;29:1071-1077.
14. Karatas F, Karatepe M, Baysar A. Determination of free malondialdehyde in human serum by high-performance liquid chromatography. Anal Biochem 2002; 311: 76-79.
15. Stalikas CD, Konidari CN. Analysis of malondialdehyde in biological matrices by capillary gas chromatography with electron-capture detection and mass spectrometry. Anal Biochem 2001;290:108-115.
16. Kroepfl JM, Pekovits K, Stelzer I, Fuchs R, Zelzer S, Hofmann P, et al. Exercise increases the frequency of circulating hematopoietic progenitor cells, but reduces hematopoietic colony-forming capacity. Stem Cells Dev 2012;21:2915-2925.
17. Chen JL, Huang YJ, Pan CH, Hu CW, Chao MR. Determination of urinary malondialdehyde by isotope dilution LC-MS/MS with automated solid-phase extraction: a cautionary note on derivatization optimization. Free Radic Biol Med 2011;51:1823-1829.
18. Health and Human Services Food and Center for Drug Evaluation and Research of the U.S. Department of Drug Administration. 2001 http://www.fda.gov/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/ ucm064964. htm (accessed 26.04.11).
19. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two diff erent analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem 1983;21:709-720.
20. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
21. Spickett CM, Wiswedel I, Siems W, Zarkovic K, Zarkovic N. Advances in methods for the determination of biologically relevant lipid peroxidation products. Free Radic Res 2010;44:1172-1202.
22. Liu J, Yeo HC, Doniger SJ, Ames BN. Assay of aldehydes from lipid peroxidation: gas chromatography-mass spectrometry compared to thiobarbituric acid. Anal Biochem 1997;245:161-166.